HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites
 


Regeneron Pharmaceuticals Company News

Tue, 07 May 2019 17:09:00 GMT
Regeneron Stock Is Diving Because Earnings Disappointed - Barron's
<ol><li> Regeneron Stock Is Diving Because Earnings Disappointed Barron's</font></li><li><a href="/url/?u=https://finance.yahoo.com/news/regeneron-pharmaceuticals-regn-q1-2019-212402997.html" target="_blank">Regeneron Pharmaceuticals (REGN) Q1 2019 Earnings Call Transcript Yahoo Finance</font></li><li><a href="/url/?u=https://seekingalpha.com/article/4261091-regeneron-pharmaceuticals-inc-regn-ceo-leonard-schleifer-q1-2019-results-earnings-call" target="_blank">Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q1 2019 Results - Earnings Call Transcript Seeking Alpha</font></li><li><a href="/url/?u=https://www.schaeffersresearch.com/content/news/2019/05/07/regeneron-pharmaceuticals-set-to-test-chart-support-after-earnings" target="_blank">Regeneron Pharmaceuticals Set to Test Chart Support After Earnings Schaeffers Research</font></li><li><a href="/url/?u=https://investorplace.com/2019/05/regeneron-pharmaceuticals-earnings-miss-hits-stock/" target="_blank">Regeneron Pharmaceuticals Earnings: REGN Stock Drops on Q1 Miss Investorplace.com</font></li><li><strong><a href="/url/?u=https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWl3Ni1qeGpZQU1FZlFLajhCYWtfUS1LQUFQAQ?oc=5" target="_blank">View full coverage on Google News</a></strong></li></ol>
Mon, 06 May 2019 19:33:49 GMT
Regeneron Pharmaceuticals Expected to Earn $5.48 a Share - TheStreet.com
Regeneron Pharmaceuticals Expected to Earn $5.48 a Share TheStreet.com Regeneron Pharmaceuticals (REGN - Get Report) is expected to report quarterly earnings of $5.48 a share on sales of $1.8 billion before the market opens on ...
Mon, 22 Apr 2019 07:00:00 GMT
Why Are Shares Of Regeneron Tanking - Seeking Alpha
Why Are Shares Of Regeneron Tanking Seeking Alpha Markets sold Regeneron stock so much so that shares are back at the $330 range. Selling irrational when Dupixent's prospects are reviewed. Buy the dip or ...
Mon, 15 Apr 2019 07:00:00 GMT
Stalking an Entry in Regeneron Pharmaceuticals - TheStreet.com
Stalking an Entry in Regeneron Pharmaceuticals TheStreet.com A low-risk countertrend options trade may be worth a look in this name....REGN.
Wed, 08 May 2019 13:42:33 GMT
Regeneron Discloses Two Deaths from its Bispecific Antibody RGN1979 - BioSpace
Regeneron Discloses Two Deaths from its Bispecific Antibody RGN1979 BioSpace Share of Regeneron fell more than 6 percent Tuesday after the company disclosed two deaths related to its vaunted bispecific antibody program.
Tue, 07 May 2019 22:38:25 GMT
May 07, 2019 - Parnassus Endeavor Fund Buys AbbVie Inc, Biogen Inc, Regeneron Pharmaceuticals Inc, Sells Starbucks Corp, United Parcel Service Inc, CVS Health Corp - GuruFocus.com
May 07, 2019 - Parnassus Endeavor Fund Buys AbbVie Inc, Biogen Inc, Regeneron Pharmaceuticals Inc, Sells Starbucks Corp, United Parcel Service Inc, CVS Health Corp GuruFocus.com Investment company Parnassus Endeavor Fund buys AbbVie Inc, Biogen Inc, Regeneron Pharmaceuticals Inc, Perrigo Co PLC, Apple Inc, Mastercard Inc, ...
Fri, 26 Apr 2019 07:00:00 GMT
Regeneron slips 2% on conditional approval recommendation in Europe for Libtayo - Seeking Alpha
Regeneron slips 2% on conditional approval recommendation in Europe for Libtayo Seeking Alpha The European Medicines Agency's advisory group CHMP has adopted a positive opinion backing conditional approval for Regeneron Pharmaceuticals' ...
Wed, 17 Apr 2019 07:00:00 GMT
Why Regeneron Pharmaceuticals, Inc. (REGN) shares price is down -3.24% today - Find News
Why Regeneron Pharmaceuticals, Inc. (REGN) shares price is down -3.24% today Find News Today's big question for investors is, “what's going on with Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stock? Its price is nose-diving -11.93 points, ...
Thu, 09 May 2019 13:30:54 GMT
Average Broker Rating Watch for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Glenwood Guardian
Average Broker Rating Watch for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Glenwood Guardian Sell-side analysts often undertake stock analysis to give their opinions of whether they believe that shares should be bought, sold, or held. Using ratings.
Thu, 02 May 2019 14:04:00 GMT
Regeneron's one drug that means billions in sales, millions in salaries - Albany Business Review - Albany Business Review
Regeneron's one drug that means billions in sales, millions in salaries - Albany Business Review Albany Business Review We've written plenty over the years about the manufacturer's growth from a few hundred people in Rensselaer County to more than 2600 — with more on the ...